[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN112501249A - Preparation method, sequencing method and kit of RNA library - Google Patents

Preparation method, sequencing method and kit of RNA library Download PDF

Info

Publication number
CN112501249A
CN112501249A CN201910868845.5A CN201910868845A CN112501249A CN 112501249 A CN112501249 A CN 112501249A CN 201910868845 A CN201910868845 A CN 201910868845A CN 112501249 A CN112501249 A CN 112501249A
Authority
CN
China
Prior art keywords
rna
optionally
sequencing
cdna
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910868845.5A
Other languages
Chinese (zh)
Other versions
CN112501249B (en
Inventor
甘广丽
张萌
李改玲
李妍
张娟
曾立董
沈丽婉
骆明杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genemind Biosciences Co Ltd
Original Assignee
Genemind Biosciences Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genemind Biosciences Co Ltd filed Critical Genemind Biosciences Co Ltd
Priority to CN201910868845.5A priority Critical patent/CN112501249B/en
Priority to PCT/CN2020/111330 priority patent/WO2021052124A1/en
Publication of CN112501249A publication Critical patent/CN112501249A/en
Application granted granted Critical
Publication of CN112501249B publication Critical patent/CN112501249B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06Biochemical methods, e.g. using enzymes or whole viable microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to the technical field of biology, in particular to a preparation method, a sequencing method and a kit of an RNA library. The invention discloses a method for preparing an RNA library, which comprises the steps of carrying out reverse transcription by taking RNA as a template to generate first-strand cDNA, and obtaining an RNA/cDNA hybrid; adding a first preset sequence to at least one end of an RNA/cDNA hybrid to form the RNA/DNA hybrid, wherein the RNA/DNA hybrid is an RNA library, and the first preset sequence is positioned at least one end of a cDNA chain. The method for preparing the RNA library is simple and quick to operate, the constructed RNA library can be directly used for sequencing, and the method has no two-chain cDNA synthesis process, namely no cDNA amplification and enrichment process, so that bias and errors generated by PCR amplification and enrichment can be avoided. Meanwhile, the invention discloses an RNA sequencing method for directly determining cDNA sequence information to obtain RNA sequence information. The invention also discloses a RAN test kit, and RNA libraries and sequencing of the RNA libraries can be constructed by using the kit.

Description

Preparation method, sequencing method and kit of RNA library
Technical Field
The invention relates to the technical field of biology, in particular to a preparation method, a sequencing method and a kit of an RNA library.
Background
RNA sequencing research is the basis of gene function and structure research, can research gene function and structure from the whole level, and can carry out deeper and more complete research on a transcriptome through RNA sequencing against the development of sequencing technology.
To achieve sequencing of RNA, it is often necessary to convert RNA into cDNA and then sequence, i.e., construct a cDNA library and then sequence. Library construction prior to RNA sequencing not only directly affects RNA detection time, but also affects sequencing results. At present, the RNA library construction is generally divided into total RNA library construction, mRNA library construction, small RNA library construction and the like. The currently common RNA library construction process mainly comprises the following steps: breaking RNA at high temperature, inverting broken RNA into cDNA, synthesizing double-stranded DNA, purifying the double-stranded DNA by magnetic beads, repairing the tail end, adding A base, adding a joint, purifying, PCR (optional) and controlling library quality. The library building process generally needs one day, consumes long time, has multiple library building steps and has high reagent cost. Meanwhile, when an RNA sequencing library constructed based on conventional library construction operation is sequenced, a sequencing result contains data of two cDNAs, and a process of synthesizing double-stranded DNA by PCR is introduced in the library construction process, so that the data repetition rate is high, and bias and errors are amplified.
In order to improve the data utilization rate and the coverage of genes and reduce the data analysis burden, the optimization of RNA library building and RNA sequencing methods is imperative.
Disclosure of Invention
The invention provides a novel preparation method of an RNA library, which constructs an RNA/DNA hybrid library by quantitatively adding a linker, has simple and rapid operation, can be directly used for sequencing, has no two-strand cDNA synthesis process, namely a cDNA amplification and enrichment process, and can avoid bias and errors generated by PCR amplification and enrichment. Meanwhile, the RNA sequencing method provided by the invention can sequence the first strand cDNA, improve the genome coverage of sequencing data, improve the effective utilization rate (low repetition rate) of the sequencing data and reduce the data analysis burden because the sequencing data does not have the interference of the second strand cDNA sequencing data.
In one aspect, the present invention provides a method for preparing an RNA library, the method comprising the steps of:
reverse transcription is carried out by taking RNA as a template to generate first strand cDNA, and an RNA/cDNA heterozygote is obtained;
adding a first predetermined sequence to at least one end of an RNA/cDNA hybrid to form an RNA/DNA hybrid, wherein the RNA/DNA hybrid is an RNA library, and the first predetermined sequence is positioned at least one end of a cDNA chain. Wherein the predetermined sequence is a sequence of which the sequence is known.
In one example of the present invention, in the above-mentioned method, the reverse transcription is performed in a first reaction system, the first reaction system comprises a reverse transcriptase and a primer, and the reverse transcriptase does not have an RNA degradation function. Ensuring that the reverse transcriptase has transcription activity but not RNA degradation activity, in order to ensure that RNA/cDNA hybrids are formed for subsequent reactions after reverse transcription.
In one example of the present invention, in the above-mentioned method, the reverse transcriptase in the first reaction system is at least one selected from the group consisting of M-muLV enzyme and engineered enzyme thereof, wherein the M-muLV enzyme is M-muLV wild-type enzyme; the M-M mu LV engineering enzyme is an M-M mu LV mutant enzyme, but still has M-M mu LV reverse transcription activity, and C base is added at the tail end of the reverse transcription product cDNA. When M-M μ LV was reverse transcribed using RNA as template, 3 more C bases were added from the 3' end. When reverse transcription is carried out, the used enzyme is not limited to M-M mu LV enzyme and engineering enzyme thereof, and when the used transcriptive enzyme can realize the function of tailing at the 3' end of cDNA, the aim of adding a joint at a single end of RNA/cDNA can be fulfilled. By tailed, it is meant that the 3' unpaired template of the amplified strand is single stranded.
In one example of the present invention, the primer used for reverse transcription in the above method may be a random primer, and the reverse transcription is performed by using the random primer, which is not selective for the template RNA, and can ensure that all the template RNA is reverse transcribed as much as possible. It is understood that reverse transcription may be performed using different primers, such as mRNA, and that polyT primers and random primers may be used, depending on the purpose of the experiment. Whether a polyT primer or a random primer, a second predetermined sequence may be optionally added to the 5' end of the primer, and the second predetermined sequence may be used for bidirectional sequencing of the library and for adding a linker complementary to the sequence.
In one example of the present invention, the nucleotide at the 5' end of the primer is a blocked nucleotide, the blocked nucleotide cannot add a nucleotide sequence at the 5' end of the primer by a ligation reaction, the type of the blocked nucleotide is that the phosphate group of the nucleotide is blocked, or the nucleotide end has modifications such as biotin (biotin), spacer C18 (18), spacer C9, spacer C3 or NH 2C 12 to increase steric hindrance and prevent the ligation reaction between nucleotides, and the nucleotide at the 5' end of the primer is a blocked nucleotide to prevent the first predetermined sequence from being added at the 5' end of the primer by the ligation reaction, thereby ensuring the directionality of the addition of the first predetermined sequence, i.e., the first predetermined sequence is added at the 3' end of the cDNA.
In one example of the present invention, the above method, wherein the reaction of adding the first predetermined sequence and the reverse transcription are performed simultaneously in the first reaction system, i.e., the reverse transcription of RNA and the reaction of adding the first predetermined sequence are performed simultaneously in one reaction system, eliminates the purification step after the reverse transcription of RNA.
It should be noted that a purification step can be selectively added between the reverse transcription of RNA and the reaction of adding the first predetermined sequence, and whether the addition of the purification step does not affect the effect of linker addition. In one example, reverse transcription of RNA and addition of a first predetermined sequence reaction are carried out by mixing reagents required for the two-step reaction (e.g., a reagent ligase required for the linker ligation reaction, a reagent reverse transcriptase required for the reverse transcription reaction, etc.) together to form a reaction system. It will be appreciated by those skilled in the art that the optimal buffers required for the different enzymes may be different and that it is uncertain whether the two enzymes will function properly when mixed together, as the two enzymes may interact. The simultaneous performance of reverse transcription of RNA and addition of the first predetermined sequence reaction is a simplified process step obtained after several attempts. The RNA library constructed by the RNA library preparation method is successfully added with the linker, as shown in the detection result of Th-2 in figure 3. The reverse transcription of RNA and the reaction of adding the first preset sequence are carried out synchronously, so that the operation steps of the experimental process can be reduced, the experimental operation is simplified, and the experimental result is not influenced.
In the above method, the first predetermined sequence is located at least one end of the cDNA strand in three cases: in the first case, the first preset sequence is positioned at the 3 'end of the cDNA chain, and only the 3' end of the cDNA chain in the constructed RNA library contains the first preset sequence; in the second case, the first predetermined sequence is located at the 5 'end of the cDNA strand, and only the 5' end of the cDNA strand in the constructed RNA library contains the first predetermined sequence; in a third case, the first predetermined sequence is located at the 5' end and the 3' end of the cDNA strand, and only the 3' end of the cDNA strand in the constructed RNA library contains the first predetermined sequence.
In one example of the present invention, two methods can be used to add a first predetermined sequence to at least one end of a cDNA strand, the first method being: a first predetermined sequence is added to at least one end of the cDNA strand by ligation or polymerization. When a first predetermined sequence is added to at least one end of a cDNA strand by a ligation reaction, a ligase is included in the first reaction system. Further, the first reaction system further comprises a linker which is a double-stranded DNA comprising a first strand and a second strand, the linker being linked to the RNA/cDNA hybrid to obtain an RNA-DNA hybrid having a first predetermined sequence at least one end of the cDNA strand. When the second strand is linked 5 'to the cDNA 3', preferably the second strand is longer than the first strand, and the probe is used to capture the cDNA strand, the capture temperature of the probe, e.g., higher than the annealing temperature of the linker, is selected to reduce the effect of the first strand on the capture of the second strand by the probe, e.g., the sequences shown in SEQ ID NO 1 and SEQ ID NO 2. In another preferred embodiment, the second strand is linked 5' to the 3' end of the cDNA, the first strand and the second strand are not modified at the 3' end by a hydroxyl group or the hydroxyl group at the 3' end is blocked, the first strand cannot be added to the 5' end of the cDNA by a ligation reaction or the second strand is added in reverse to the 5' end of the cDNA, which ensures that only the cDNA 3' end is added with the first predetermined sequence.
The second method is as follows: adding a first predetermined sequence to at least one end of the cDNA strand by polymerization. When the first predetermined sequence is added by polymerization, the enzyme used for polymerization is the same as the enzyme used for reverse transcription. The same enzyme is used for amplification, the first strand cDNA generated by reverse transcription does not need to be purified, and the single-chain linker is added to carry out amplification reaction, so that the use amount of the enzyme and a purification reagent can be reduced, the operation steps are simplified, and the cost is reduced. Further, when the 3 'end of the cDNA strand in the RNA/cDNA hybrid is a single stranded end, the first reaction system comprises a single stranded DNA linker, the linker and the 3' end of the cDNA strand are complementary, and the linker is longer than the complementary single stranded end. Further, the linker is 10bp to 60bp longer than the single-stranded end of the 3' end of the cDNA strand, preferably 20bp to 50bp longer, as shown in SEQ ID NO 3. The 3' end of the single-stranded DNA linker is complementarily paired with the 3' end of the first strand cDNA, the first strand cDNA is extended and amplified, and a known sequence is added to the 3' end of the first strand cDNA in the amplified product.
The multiple RNA library building methods are simple and quick to operate because the reverse transcription reaction and the joint adding reaction are synchronously carried out; the reverse transcription reaction and the amplification reaction use the same enzyme, so that the use amount of the enzyme can be reduced, and the cost is saved; the constructed library is an RNA/DNA hybrid, can be directly used for sequencing, and can avoid bias and errors generated by PCR amplification enrichment because the method has no two-chain cDNA synthesis process, namely no cDNA amplification enrichment process; directional addition of linkers can be achieved, e.g., adding known sequences only 3' to the first strand cDNA, and when such a library is used for sequencing, the sequencing data is directional, facilitating analysis of the sequencing data.
In a second aspect, the present invention provides an RNA library prepared by the method of any one of the preceding claims. The RNA library was used directly for sequencing.
The third invention of the invention provides an RNA sequencing method, which comprises the following steps:
capturing DNA in the RNA library by the probe to form a probe/DNA hybrid;
sequencing the probe/DNA hybrid to obtain the DNA sequence information;
determining at least a portion of said RNA sequence information based on DNA sequence information;
the probe is complementary paired to the first predetermined sequence.
It will be appreciated that the purpose of complementary pairing of the known sequence to the probe is for probe capture, and therefore complementary pairing of the known sequence to the probe does not require that all of the sequences in the known sequence be complementary paired to the probe, and in the example it can also be seen that two bases at the 3' end of the known sequence are not complementary paired to the probe, and that there are also a plurality of bases in the probe that are not paired in the known sequence. When the base at the 3' end of the known sequence does not complementarily match the probe, the first strand cDNA captured in the amplification sequencing will not be amplified using the probe as a template, thereby reducing the interference of the sequencing signal.
In one example, the sequencing method described above, the sequencing is performed on a solid phase substrate with probes. And (3) directly sequencing after the probe captures the DNA, taking the probe as a sequencing primer, and enabling the first preset sequence to be located at the 3' end of the cDNA and to be complementary and paired with the probe.
In one example, the above step comprises a step of denaturing the RNA library, and after obtaining single-stranded DNA after denaturing the RNA library, the probe captures the DNA. The RNA library contains RNA and cDNA and is double-stranded, and when the probe capture is carried out, the double strand becomes single-stranded, so that the probe can be hybridized and complemented with a known sequence at the 3' end of the first strand cDNA to form a hybrid complex.
In one example, the captured DNA sequence is subjected to bidirectional sequencing, and sequencing is performed by adding a sequencing primer, the sequence of which is identical to the second predetermined sequence.
The multiple RNA sequencing methods can be used for realizing direct sequencing of the first strand cDNA, sequencing data have directionality, and as can be seen from sequencing results in examples, the sequencing method can improve genome coverage of the sequencing data, and meanwhile, due to the fact that interference of the sequencing data of the second strand cDNA is not generated in the sequencing data, the effective utilization rate (low repetition rate) of the sequencing data is improved, and data analysis burden is reduced.
The fourth aspect of the invention provides an RNA sequencing kit, wherein the kit is used for implementing the preparation method of the RNA library or the RNA sequencing method, and comprises the probe, reverse transcriptase and a joint; wherein the adaptor is single-stranded DNA or double-stranded DNA, and the probe is complementarily paired with the first preset sequence.
Further, the kit may further comprise a ligase for ligating the double-stranded DNA to the RNA/DNA heteroduplex.
In one example, the reverse transcriptase in the kit is M-muLV enzyme and its engineered enzyme, which is used for reverse transcription to generate first strand cDNA of RNA.
In one example, the adaptor is a double-stranded DNA, such as the sequences shown in Seq ID No.1 and Seq ID No. 2.
In one example, the linker is a single-stranded DNA; the sequence is shown as Seq ID No. 3.
In one example, the probe is a sequence represented by Seq ID No. 4.
The RNA sequencing kit can be used for constructing the RNA library and sequencing the RNA library.
Drawings
FIG. 1 is a diagram showing the detection results of the library labchip method in example 1 of the present invention;
FIG. 2 is a diagram showing the detection results of the library labchip method in example 2 of the present invention;
FIG. 3 is a diagram showing the detection results of the library labchip method in example 3 of the present invention;
FIG. 4 is a diagram showing the detection results of the library labchip method in example 4 of the present invention;
FIG. 5 is a diagram showing the results of detection by the library labchip method in example 5 of the present invention.
Interpretation of terms:
as used herein, "nucleic acid", "nucleic acid molecule" and "nucleic acid fragment", including DNA, RNA-DNA and/or cDNA, double-stranded or single-stranded, are sequences composed of nucleotides and/or nucleotide analogs (derivatives).
As used herein, "double-stranded nucleic acid" includes nucleic acids that are also two-stranded, formed from DNA, RNA-DNA and/or cDNA.
As used herein, "linker", "first predetermined sequence" and "second predetermined sequence" refer to a nucleic acid fragment of known sequence.
An "RNA library" as referred to herein is a library that is reverse transcribed from an RNA template to produce RNA.
Detailed Description
Unless otherwise defined, the terms used herein have the ordinary meanings as commonly understood in the art to which this invention belongs.
The present invention will now be described with reference to specific examples and figures, which are provided for illustrative purposes only and are not to be construed as limiting the invention. The examples, where specific techniques or conditions are not indicated, are in accordance with routine experimentation or with the manufacturer's instructions. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products commercially available.
In the examples, the RNA was obtained from the same DH5 a-containing strain (Bio-Rad: B528411-0001). Total RNA of DH5a strain is extracted by using reagent and operation method of the total RNA kit of Tiangen DP430 bacteria.
The specific sequences of the double-stranded linker, single-stranded linker and probe used in the examples are as follows:
the D9TS-ad linker is a double-stranded nucleic acid formed from two single-stranded nucleic acids (a first strand and a second strand):
first chain 5'-AGATGTGTATAAGAGACAGTGGG-3' (Seq ID No.1)
Second chain 5'-ACTGTCTCTTATACACATCTGAGTGGAACTGGATGGTCGCAGGTATCAAGGATT-3' (Seq ID No.2)
D9-TSO linker: single-stranded nucleic acid
5’-GGTCCTTGATACCTGCGACCATCCAGTTCCACTCAGATGTGTATAAGAGACAGTGGG-3’(Seq ID NO.3)
And (3) probe:
5’-TTTTTTTTTTTCCTTGATACCTGCGACCATCCAGTTCCACTCAGATGTGTATAAGAGACAG-3’(Seq ID NO.4)
example 1
High temperature disruption of RNA
100ng of RNA was broken into 100-300bp RNA fragments by the following steps:
1) 5xFS buffer (Thermo Fisher Cat No.: 18064014) thawing and mixing by inversion, preparing the reaction system according to the following table 1:
TABLE 1
Control A Experiment B
RNA(50ng/μL) 2μL 2μL
5xFS buffer 4μL 4μL
ddH2O 2μL 2μL
Total 8μL 8μL
2) High temperature disruption reactions were performed in a PCR instrument: lid (PCR hot lid) 105 deg.C, 94 deg.C for 7min, immediately cooling on ice;
3) immediately after the cooling reaction was completed, the next inversion reaction was carried out.
2. First Strand cDNA Synthesis
1) In the disconnected reaction tube, a reaction system was prepared according to table 2:
TABLE 2
Figure BDA0002202077090000051
Figure BDA0002202077090000061
2) Reaction conditions are as follows: 10min at 25 ℃ and 15min at 42 ℃ to obtain RNA/cDNA hybrid fragments after the reaction is finished.
3. Add the piecing
2 μ L D9TS-ad (11uM) linker, 22 μ L Blunt/TA Ligase Master Mix (cat # NEB M0367) was added to the first strand cDNA synthesis tube of experiment B and the ligation product was library B after 15min at room temperature.
4. Purification of
Purifying the first strand cDNA synthesis product of the control A once by using 1.8x Ampure XP beads, and eluting to obtain 10 mu L of supernatant containing RNA/cDNA heterozygous fragment A, wherein the supernatant is used as a fragment control of an experimental library B;
purify the adaptor-added product of experiment B once with 0.8X Ampure XP beads, elute to give 10. mu.L of supernatant 1, purify the supernatant once with 1.2X Ampure XP beads, elute to give 10. mu.L of supernatant 2. The supernatant 2 was examined by the labchip method, and the results are shown in FIG. 1, and the library B (experimental B library) was about 70bp longer than the heterozygous fragment A (control A fragment), indicating that the library B was successfully ligated with a single-ended linker.
5. Hybrid Capture
The probes (SEQ ID NO:4) were immobilized on a chip using the method disclosed in the specification of published patent application CN201510501968.7, and the prepared libraries 1 and 2 were diluted with 3 XSSC hybridization solution and then hybridized with the probes immobilized on a chip. The number of hybridizations of the linker sequence to the probe was then determined from the signal of Cy 3.
The procedure for library chip hybridization was as follows:
(1) chip selection: the base glass of the chip used was an epoxy-modified glass chip of SCHOTT company, and the probe shown in Seq ID No.4 was immobilized by a method of reacting an amino group on the probe with an epoxy group on the surface of the chip, for example, as disclosed in published patent application No. CN201811191589.2, and the probe density was about 18000Dot/FOV in a 110X 110. mu.M area, that is, 18000 bright spots in a 110X 110. mu.M field of view.
(2) Preparing a hybridization solution: as shown in Table 3, the hybridization solution was prepared using 20 XSSC buffer (Sigma, # S6639-1L) at a final concentration of 3 XSSC, and the library at a final concentration of 1nM in a total volume of 40. mu.L. The prepared hybridization solution is denatured at 95 ℃ for 2min and rapidly cooled on ice.
TABLE 3
20 XSSC buffer 6μL
Library
1 or library 2 Final concentration of 1nM
Enucleated acid water Make up to 40. mu.L
(3) And (3) quickly loading the denatured hybridization solution onto a chip, and then placing the chip at 55 ℃ for 30min to hybridize the library and the probe on the surface of the chip.
(4) The chip was washed sequentially with 3 XSSC, 1 XSSC, and 0.1 XSSC.
Sequencing the library captured by hybridization using the GenoCare third generation sequencing platform, and the sequencing results are shown in table 15.
Example 2
High temperature disruption of RNA
100ng of RNA was disrupted into a 100-and 300-bp fragment by the following steps:
1) the reagents were thawed and mixed by inversion, and the reaction system was prepared according to table 4:
TABLE 4
T1 (control) T2 (experiment)
RNA(50ng/μL) 2μL 2μL
Frag/1st strand buffer (Tiangen NG308) 5μL 5μL
ddH2O 3μL 3μL
Total 10μL 10μL
2) High temperature disruption reactions were performed in a PCR instrument: and (3) Tiangen: cooling immediately on ice at 94 ℃ for 10min and lid 105 ℃;
3) immediately after the cooling reaction was completed, the next inversion reaction was carried out.
2. First Strand cDNA Synthesis
1) In the disconnected reaction tube, a reaction system was prepared according to table 5:
TABLE 5
Figure BDA0002202077090000071
2) Reaction conditions are as follows: 10min at 25 ℃ and 15min at 42 ℃ to obtain RNA/cDNA hybrid fragments after the reaction is finished.
3. Add the piecing
2 μ L D9TS-ad (11uM) linker, 22 μ L Blunt/TA Ligase Master Mix (cat # NEB M0367) was added to the reverse product of T2 and the ligation product was library T2 after 15min at room temperature.
4. Purification of
The first strand cDNA synthesis product of control T1 was purified once with 1.8X (36. mu.L) Ampure XP beads, eluted to give 10. mu.L supernatant containing RNA/cDNA hybrid T1, used as a fragment control for the experimental library T2;
the linker-added product of experiment T2 was purified once with 0.8X Ampure XP beads, eluting to give 10. mu.L of supernatant 1, and then supernatant 1 was purified once with 1.2X Ampure XP beads, eluting to give 10. mu.L of supernatant 2, and 2L of supernatant was assayed by the labchip method, as shown in FIG. 2, with the assay results for library T2(T2 experiment) being about 70bp greater than for the hybrid T1(T1 control), indicating that library T2 was successfully single-ended linker-added.
5. Hybrid Capture
The hybridization capture step is the same as the "hybridization capture" protocol of step 5 of example 1.
Sequencing the library captured by hybridization using the GenoCare third generation sequencing platform, and the sequencing results are shown in table 15.
Example 3
High temperature disruption of RNA
100ng of RNA was disrupted into a 100-and 300-bp fragment by the following steps:
1) 5xFS buffer (Thermo Fisher Cat No.: 18064014) thawing and mixing by inversion, preparing the reaction system according to Table 6:
TABLE 6
Figure BDA0002202077090000072
Figure BDA0002202077090000081
2) High temperature disruption reactions were performed in a PCR instrument: placing at 94 deg.C for 7min, lid 105 deg.C on ice immediately and cooling;
3) immediately after the cooling reaction was completed, the next inversion reaction was carried out.
2. First strand cDNA Synthesis, ligation reaction
1) In the disconnected reaction tube, a reaction system was prepared according to table 7:
TABLE 7
Figure BDA0002202077090000082
2) 10min at 25 ℃, 15min at 42 ℃ and 15min at room temperature, and adding a joint product to obtain an RNA/cDNA heterozygous segment after the reaction is finished, so as to respectively obtain a product heterozygous segment Th-1 and a library Th-2.
3. Purification of
Control Th-1 was purified once with 1.8X (36. mu.L) Ampure XP beads, eluted to give 10. mu.L supernatant containing RNA/cDNA hybrid fragment Th-1, used as a fragment control for the experimental Th-2 library;
experimental Th-2 was purified once with 0.8x Ampure XP beads, eluting to give 10. mu.L of supernatant 1, and then supernatant 1 was purified once with 1.2x Ampure XP beads, eluting to give 10. mu.L of supernatant 2. The supernatant 2 was examined by the labchip method, and the results are shown in FIG. 3, in which the library Th-2 (experimental Th-2 library) was about 70bp longer than the heterozygous fragment Th-1 (control Th-1 fragment), indicating successful application of the single-ended linker to the library Th-2.
4. Hybrid Capture
The hybridization capture step is the same as the "hybridization capture" protocol of step 5 of example 1.
Sequencing the library captured by hybridization using the GenoCare third generation sequencing platform, and the sequencing results are shown in table 15.
Example 4
High temperature disruption of RNA
100ng of RNA was broken into 100-300bp RNA fragments by the following steps:
1) 5xFS buffer (Thermo Fisher Cat No.: 18064014) thawing and mixing by inversion, preparing the reaction system according to the following table 1:
TABLE 8
Figure BDA0002202077090000083
Figure BDA0002202077090000091
2) High temperature disruption reactions were performed in a PCR instrument: lid (PCR hot lid) 105 deg.C, 94 deg.C for 7min, immediately cooling on ice;
3) immediately after the cooling reaction was completed, the next inversion reaction was carried out.
2. First Strand cDNA Synthesis
1) In the disconnected reaction tube, a reaction system was prepared according to table 2:
TABLE 9
Figure BDA0002202077090000092
2) Reaction conditions are as follows: 10min at 25 ℃ and 15min at 42 ℃ to obtain RNA/cDNA hybrid fragments after the reaction is finished.
3. Add the piecing
2 mu L D9-TSO (10uM) joint is added into a first strand cDNA synthesis tube of experiment Y2, and the ligation product is the library Y2 at 42 ℃ for 5 min.
4. Purification of
The first strand cDNA synthesis product of control Y1 was purified once with 1.8X Ampure XP beads, eluted to give 10. mu.L of supernatant containing RNA/cDNA hybrid fragment A, used as fragment control for experimental library Y2;
purify the adaptor-added product of experiment B once with 0.8X Ampure XP beads, elute to give 10. mu.L of supernatant 1, purify the supernatant once with 1.2X Ampure XP beads, elute to give 10. mu.L of supernatant 2. The supernatant 2 was examined by the labchip method and the results are shown in FIG. 4, the library Y2 (Experimental Y2 library) was about 70bp longer than the hybrid fragment Y1 (control Y1 fragment), indicating that the library Y2 was successfully ligated with a single-ended linker.
5. Hybrid Capture
The hybridization capture step is the same as the "hybridization capture" protocol of step 5 of example 1.
Sequencing the library captured by hybridization using the GenoCare third generation sequencing platform, and the sequencing results are shown in table 15.
Example 5
This example is a RNA library-building sequencing procedure used in the prior art. In total 3 experiments were performed in parallel, with sample designations C1, C2, and C3, respectively, and 100ng of RNA was taken from each sample for subsequent experiments. In the library construction process, a kit (cargo number is NR102) for constructing a quick Tiangen RNA library is used.
High temperature disruption of RNA
100ng of RNA was disrupted into a 100-and 300-bp fragment by the following steps:
1) unfreezing Frag/1st strand buffer in the kit, reversing and mixing uniformly, and preparing a reaction system according to the following table 10:
watch 10
Figure BDA0002202077090000093
Figure BDA0002202077090000101
2) High temperature disruption reactions were performed in a PCR instrument: placing at 94 deg.C for 7min, lid 105 deg.C on ice immediately and cooling;
3) immediately after the cooling reaction was completed, the next inversion reaction was carried out.
2. First Strand cDNA Synthesis
1) In the reaction tube after the breakage, a reaction system was prepared as shown in table 11:
TABLE 11
Figure BDA0002202077090000102
2) Reaction conditions are as follows: 10min at 25 ℃ and 15min at 42 ℃ to obtain RNA/cDNA hybrid fragments after the reaction is finished, and immediately synthesizing second strand cDNA.
3. Second Strand cDNA Synthesis
The second strand cDNA synthesis reaction was configured in a cleavage tube according to table 12:
TABLE 12
Component name Volume of μ L
RNA fragments 20
2st Strand Buffer 8.5
2st Strand Enzyme Mix 3.5
Nuclease-Free ddH2O 48
Total 80
Reaction conditions are as follows: 60min at 16 ℃ and hold at 4 ℃, and starting purification operation after the reaction is finished.
4. Purification of
And purifying the product after the primary double-chain synthesis by using 1.8x Ampure XP beads, and eluting to obtain 35 mu L of supernatant, namely obtaining a double-chain cDNA sample.
5. End repair/dA addition
The end repair/dA addition reaction system was configured as shown in Table 13:
watch 13
Component name Volume (μ l)
cDNA sample 35
10×ERA buffer 5
5×ERA Enzyme Mix 10
Total 50
Reaction conditions are as follows: the following reactions were carried out in a 4 ℃ pre-cooled PCR instrument with the PCR hot lid temperature set at 70 ℃ and the reaction flow set at 20 ℃ for 30min, 65 ℃ for 30min, 4 ℃ hold. After the reaction procedure was completed, the end repair/dA addition product was obtained and the reaction product was placed on ice immediately into the adaptor ligation step.
6. Joint connection
The linker ligation reaction system was configured according to the system shown in Table 14:
TABLE 14
Component name Volume (μ l)
End repair/dA addition products 50
D9TS-ad (11uM) joint 5
Ligase Buffer 20
TIANSeq DNA Ligase 10
Nuclease-Free ddH2O 15
Total 100
Reaction conditions are as follows: the following reactions were carried out in a PCR instrument with the temperature of the PCR hot lid set at 40 ℃ or less, the reaction flow set at 20 ℃ for 15min, 4 ℃ hold. After the reaction procedure is finished, the linker ligation product is obtained.
7. Purification step
Purifying the adaptor-ligated product with 0.8x Ampure XP beads, eluting to obtain 35. mu.L of supernatant 1, purifying the supernatant 1 once with 1.2x Ampure XP beads, and eluting to obtain 35. mu.L of supernatant 2, thereby obtaining libraries C1, C2 and C3. The supernatant 2 was detected by the labchip method, and the results are shown in FIG. 5, and the sizes of the libraries C1, C2 and C3 were consistent with the peak values of the main bands of the linker-added libraries in FIGS. 1-4, indicating that the libraries C1, C2 and C3 were successfully added with the linker.
8. Hybrid Capture
The hybridization capture step is the same as the "hybridization capture" protocol of step 5 of example 1.
Sequencing the library captured by hybridization using the GenoCare third generation sequencing platform, and the sequencing results are shown in table 15.
Watch 15
Figure BDA0002202077090000111
Remarking: count _ all: all reads obtained after the sequencing data are subjected to quality control filtration; count _ map: the data after quality control can be compared with the reads number of the genome; count _ unmap: the data after quality control cannot be compared with the reads number of the genome; count _ unique: comparing the numbers of reads of the unique position on the genome in the reads of the genome; meanlen under various parameters: representing the average reads length under each parameter; coverage: the unique reads are spliced, the repetition is removed, and the total length of bases which can cover the genome is large; base: the total base number on the genome can be aligned in unique reads; cover _ depth, which means the coverage depth in the covered reads area; a Depth: dividing the number of bases by the number of bases of the total length of the genome to obtain the average sequencing depth; coverag%: sequencing coverage was obtained by dividing the number of length bases of coverage by the number of bases of total genome length.
The same amount of RNA library constructed in examples 1-5 was subjected to on-machine sequencing, and the specific sequencing results are shown in Table 15, as can be seen from Table 15:
the sequencing data (count _ all) for the RNA libraries (B, T2, Th-2, Y2) was about half less than the amount of sequencing data (count _ all) for the comparison libraries (C1, C2, C3). Since the RNA libraries (B, T2, Th-2, Y2) are single-ended with known sequences added, sequence capture is performed by capturing only the first strand cDNA in the library for sequencing, while the alignment libraries (C1, C2, C3) are double-ended with linkers for sequencing, and the captured nucleic acid strands are complementary two strands, the same library amount is used for machine sequencing, and the sequencing data amount is different by multiple. The reverse is true when both libraries obtain the same amount of data, the amount of machine library on the RNA library (B, T2, Th-2, Y2) is about half the amount of comparison library (C1, C2, C3);
the percent coverage of sequencing data coverage of the RNA library (B, T2, Th-2 and Y2) is far higher than that of the comparison library (C1, C2 and C3), namely the genome coverage of the sequencing data is greatly different, and the coverage of the sequencing data genome obtained by the RNA library construction and sequencing method is far higher than that of the comparison library. Since the duplication rate in Count _ unique is about 40% and the comparison libraries (C1, C2, C3) are about 90% (data not shown), and since the two-stranded cDNA amplification enrichment is performed during the construction of the comparison libraries, the bias exists, i.e., some fragments occupy less and less proportion during the amplification process, so that the fragments are filtered out as invalid data or are not effectively sequenced at all during the preliminary filtering of sequencing data, and the genome coverage rate of sequencing data of the comparison libraries is significantly lower than that of the sequencing data of the RNA libraries (B, T2, Th-2, Y2) constructed by the method of the present invention.
At the same time, it can be concluded that when the same sequencing amount (count _ all) is obtained, the% coverage of the sequencing data of the RNA libraries (B, T2, Th-2, Y2) is much higher than that of the comparative libraries (C1, C2, C3).
The foregoing is a more detailed description of the present application in connection with specific embodiments thereof, and it is not intended that the present application be limited to the specific embodiments thereof. For those skilled in the art to which the present application pertains, several simple deductions or substitutions may be made without departing from the concept of the present application, and all should be considered as belonging to the protection scope of the present application.
Sequence listing
<110> Shenzhen Zhenzhiji Biotech Limited
<120> preparation method, sequencing method and kit of RNA library
<130> PI2019004
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 23
<212> DNA
<213> Artificial Sequence
<220>
<221> misc_feature
<222> (1)..(23)
<223> linker sequence
<400> 1
agatgtgtat aagagacagt ggg 23
<210> 2
<211> 54
<212> DNA
<213> Artificial Sequence
<220>
<221> misc_feature
<222> (1)..(54)
<223> linker sequence
<400> 2
actgtctctt atacacatct gagtggaact ggatggtcgc aggtatcaag gatt 54
<210> 3
<211> 57
<212> DNA
<213> Artificial Sequence
<220>
<221> misc_feature
<222> (1)..(57)
<223> linker sequence
<400> 3
ggtccttgat acctgcgacc atccagttcc actcagatgt gtataagaga cagtggg 57
<210> 4
<211> 61
<212> DNA
<213> Artificial Sequence
<220>
<221> misc_feature
<222> (1)..(61)
<223> Probe sequence
<400> 4
tttttttttt tccttgatac ctgcgaccat ccagttccac tcagatgtgt ataagagaca 60
g 61

Claims (10)

1. A method of preparing an RNA library comprising the steps of:
reverse transcription is carried out by taking RNA as a template to generate first strand cDNA, and an RNA/cDNA heterozygote is obtained;
adding a first preset sequence to at least one end of an RNA/cDNA hybrid to form an RNA/DNA hybrid, wherein the RNA/DNA hybrid is an RNA library;
the first predetermined sequence is located at least one end of the cDNA strand.
2. The method according to claim 1, wherein the reverse transcription is performed in a first reaction system comprising a reverse transcriptase having no RNA degradation function and a primer;
optionally, the reverse transcriptase is selected from at least one of the group consisting of M-muLV enzyme and engineered enzymes thereof;
optionally, the primer is a random primer;
optionally, the 5' end of the primer is a second preset sequence;
optionally, the nucleotide at the 5' end of the primer is a blocking nucleotide.
3. The method according to claim 2, wherein the addition of the first predetermined sequence reaction and the reverse transcription reaction are carried out simultaneously in the first reaction system;
optionally, the first predetermined sequence is located at the 5' end of the cDNA strand;
optionally, the first predetermined sequence is located at the 3' end of the cDNA strand;
optionally, a first predetermined sequence is added to at least one end of the cDNA strand by ligation or polymerization.
4. The method of claim 3, wherein at least one end of the cDNA strand is provided with a first predetermined sequence by a ligation reaction, and the first reaction system comprises a ligase;
optionally, the first reaction system comprises a linker, the linker being double-stranded DNA, the linker and the RNA-DNA hybrid being linked to obtain an RNA-DNA hybrid having a first predetermined sequence at least one end of a cDNA strand;
optionally, the linker is a sequence shown in SEQ ID NO 1 and SEQ ID NO 2.
5. The method of claim 4, wherein at least one end of the cDNA strand is provided with a first predetermined sequence by polymerization;
optionally, the enzyme used for the polymerization reaction is the same as the enzyme used for the reverse transcription reaction;
optionally, the 3 'of the cDNA strand is a single stranded end, the first reaction system comprises a linker, the linker is a single stranded DNA, the linker and the 3' of the cDNA strand are complementary single stranded ends, the linker is longer than the complementary single stranded end;
optionally, the linker is 10bp to 60bp longer than the single-stranded end of the 3' end of the cDNA strand;
optionally, the length is 20bp to 50 bp;
optionally, the linker is as shown in SEQ ID NO 3.
6. An RNA library prepared by the method of any one of claims 1 to 5.
7. A method of RNA sequencing comprising the steps of:
capturing DNA in the RNA library of the claim 6 by a probe to form a probe-DNA hybrid;
sequencing the probe-DNA hybrid to obtain the DNA sequence information;
determining at least a portion of said RNA sequence information based on DNA sequence information;
the probe is complementary paired to the first predetermined sequence.
8. The sequencing method of claim 7, wherein the sequencing is performed on a solid phase substrate having a probe thereon;
optionally, performing denaturation treatment on the RNA library to obtain single-stranded DNA;
optionally, the sequencing is performed by adding a sequencing primer, the sequence of which is identical to the second predetermined sequence.
9. An RNA sequencing kit for performing the method of any one of claims 1 to 5 or for performing the sequencing method of claim 7 or 8, comprising the probe, a reverse transcriptase, a linker;
the adaptor is single-stranded DNA or double-stranded DNA, and the probe is complementarily paired with the first preset sequence.
10. The sequencing method of claim 9, wherein the kit further comprises a ligase for ligation of double-stranded DNA to RNA/DNA heteroduplexes;
optionally, the reverse transcriptase is M-muLV enzyme and its engineering enzyme;
optionally, the adaptor is a double-stranded DNA; optionally, the linker is a sequence shown in Seq ID NO.1 and Seq ID NO. 2;
optionally, the linker is a single-stranded DNA; optionally, the linker is a sequence shown in Seq ID NO. 3;
optionally, the probe is a sequence shown in Seq ID NO. 4.
CN201910868845.5A 2019-09-16 2019-09-16 Preparation method, sequencing method and kit of RNA library Active CN112501249B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201910868845.5A CN112501249B (en) 2019-09-16 2019-09-16 Preparation method, sequencing method and kit of RNA library
PCT/CN2020/111330 WO2021052124A1 (en) 2019-09-16 2020-08-26 Preparation method for rna library, sequencing method and kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910868845.5A CN112501249B (en) 2019-09-16 2019-09-16 Preparation method, sequencing method and kit of RNA library

Publications (2)

Publication Number Publication Date
CN112501249A true CN112501249A (en) 2021-03-16
CN112501249B CN112501249B (en) 2024-01-26

Family

ID=74883357

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910868845.5A Active CN112501249B (en) 2019-09-16 2019-09-16 Preparation method, sequencing method and kit of RNA library

Country Status (2)

Country Link
CN (1) CN112501249B (en)
WO (1) WO2021052124A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115820380A (en) * 2023-01-04 2023-03-21 深圳赛陆医疗科技有限公司 Microfluidic chip and preparation method and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113718023A (en) * 2021-08-23 2021-11-30 普瑞基准生物医药(苏州)有限公司 Prokaryotic ribonucleic acid direct sequencing method based on bovine nanopore sequencing technology

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004010273D1 (en) * 2003-08-16 2008-01-03 Astrazeneca Ab amplification method
CN104093854A (en) * 2011-12-02 2014-10-08 凯杰有限公司 Method and kit for characterizing rna in a composition
CN105102633A (en) * 2013-03-11 2015-11-25 以琳生物药物有限公司 Enrichment and next generation sequencing of total nucleic acid comprising both genomic DNA and cDNA
CN108588200A (en) * 2018-05-06 2018-09-28 湖南大地同年生物科技有限公司 A kind of R-Loop high-throughput sequencing libraries construction method
CN109234813A (en) * 2018-09-11 2019-01-18 南京迪康金诺生物技术有限公司 A kind of method and application constructing the special library RNA of chain
CN112689673A (en) * 2018-07-11 2021-04-20 埃克斯基因美国公司 Transposome-enabled DNA/RNA sequencing (TED RNA-SEQ)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105112408B (en) * 2015-08-14 2019-05-07 深圳市瀚海基因生物科技有限公司 The fixing means, unimolecule targeting sequencing kit and application of primer are targeted in a kind of targeting sequencing of unimolecule
AU2016326889B2 (en) * 2015-09-25 2021-03-25 Canexia Health Inc. Molecular quality assurance methods for use in sequencing

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004010273D1 (en) * 2003-08-16 2008-01-03 Astrazeneca Ab amplification method
CN104093854A (en) * 2011-12-02 2014-10-08 凯杰有限公司 Method and kit for characterizing rna in a composition
CN105102633A (en) * 2013-03-11 2015-11-25 以琳生物药物有限公司 Enrichment and next generation sequencing of total nucleic acid comprising both genomic DNA and cDNA
CN108588200A (en) * 2018-05-06 2018-09-28 湖南大地同年生物科技有限公司 A kind of R-Loop high-throughput sequencing libraries construction method
CN112689673A (en) * 2018-07-11 2021-04-20 埃克斯基因美国公司 Transposome-enabled DNA/RNA sequencing (TED RNA-SEQ)
CN109234813A (en) * 2018-09-11 2019-01-18 南京迪康金诺生物技术有限公司 A kind of method and application constructing the special library RNA of chain

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115820380A (en) * 2023-01-04 2023-03-21 深圳赛陆医疗科技有限公司 Microfluidic chip and preparation method and application thereof
CN115820380B (en) * 2023-01-04 2024-01-30 深圳赛陆医疗科技有限公司 Microfluidic chip and preparation method and application thereof

Also Published As

Publication number Publication date
WO2021052124A1 (en) 2021-03-25
CN112501249B (en) 2024-01-26

Similar Documents

Publication Publication Date Title
US20240229105A1 (en) Attenuators
US11293048B2 (en) Attenuators
EP3464634B1 (en) Molecular tagging methods and sequencing libraries
JP6768706B2 (en) Ligation assay in liquid phase
CN110409001B (en) Method and kit for constructing capture library
EP2576780B1 (en) Method for the preparation and amplification of representative and strand- specific libraries of cdna for high throughput sequencing, use thereof, kit and cartridges for automation kit
JP2007537751A (en) Method for simultaneously amplifying specific nucleic acids
EP2929056A1 (en) Methods for targeted genomic analysis
WO2010030683A1 (en) Methods of generating gene specific libraries
JP2012510810A (en) Method for reducing repetitive sequences in adapter-linked restriction fragments
JP2020536525A (en) A method for concentrating the probe and the target region to which it is applied for high-throughput sequencing
CN112501249B (en) Preparation method, sequencing method and kit of RNA library
JPS63500006A (en) Nucleic acid base sequencing method using exonuclease inhibition
WO2022007863A1 (en) Method for rapidly enriching target gene region
KR102159008B1 (en) Self-priming and replicating hairpin adaptor for NGS library preparation and method for making NGS library using the same
EP3759243B1 (en) Methods and compositions for enriching nucleic acids
CN112458085A (en) Novel molecular capture optimization probe and library construction method thereof
EP4127220B1 (en) Methods and compositions for preparing nucleic acid libraries
WO2018081666A1 (en) Methods of single dna/rna molecule counting
CN115029424A (en) Immobilized template polynucleotide paired end sequencing method
CN113795594A (en) Nucleic acid amplification and identification method
EP4012029B1 (en) Method for capturing nucleic acid molecule, preparation method for nucleic acid library, and a sequencing method
WO2018009677A1 (en) Fast target enrichment by multiplexed relay pcr with modified bubble primers
CN109610010B (en) Preparation method of FISH probe of EGFR gene
WO2021166989A1 (en) Method for producing dna molecules having an adaptor sequence added thereto, and use thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40047922

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address

Address after: 518000 podium 502A and 502B, podium 602, Luohu investment holding building, No. 112, Qingshuihe 1st Road, Qingshuihe community, Qingshuihe street, Luohu District, Shenzhen, Guangdong

Patentee after: Shenzhen Zhenmai Biotechnology Co.,Ltd.

Country or region after: China

Address before: 518000 5th and 6th floors, block 2, Shenye Jinyuan Building, No.116, Qingshuihe 1st Road, Qingshuihe street, Luohu District, Shenzhen City, Guangdong Province

Patentee before: Shenzhen Zhenmai Biotechnology Co.,Ltd.

Country or region before: China

CP03 Change of name, title or address